Adimmune
Taichung
About Adimmune
Adimmune is committed to becoming a leading biologics supplier in the Asia Pacific region, providing professional filling services. In recent years, it has cooperated with the US Protein Sciences Company (which belongs to Sanofi Vaccine Group) and successfully commercialized its recombinant protein tetravalent influenza vaccine in the US. Because Guoguang has EU GMP certification, it also teamed up with Shenzhen Tiandao Pharmaceutical Co., Ltd. to promote its low molecular enoxaparin sodium to the European market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Funding stage: IPO
- Last round: Series Unknown (Mar 2000)
- Ticker: tpe:4142
- Website: adimmune.com.tw
- Phone: 04-25381220
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/adimmune-1761594 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.